This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Frontotemporal dementia, wide, incl. Pick's disease
FTD_WIDE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
237 |
4. Check minimum number of eventsNone |
237 |
5. Include endpointsNone |
237 |
6. Filter based on genotype QC (FinnGen only) |
234 |
Control definitions (FinnGen only)
- Control exclude
- F5_DEMENTIA, G6_ALZHEIMER, G6_AD_STRICT
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Frontotemporal dementia, wide, incl. Pick's disease
based on the number of shared cases.
Similar with more cases:
- Any dementia
- Any dementia, excluding more controls
- Dementia
- Dementia, including avohilmo
- Organic, including symptomatic, mental disorders
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 234 | 104 | 130 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | 69.29 | 69.48 | 69.14 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 237
- Matched controls
- 2370
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
197.6
161
*
G31.0
ICD-10 Finland
Circumscribed brain atrophy
+∞
128.1
111
*
N05AX08
ATC
risperidone; systemic
23.6
110.4
92
62
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
14.8
85.0
94
101
F03
ICD-10 Finland
Unspecified dementia
185.2
76.2
76
6
N05AH03
ATC
olanzapine; systemic
18.7
75.6
67
49
XA800
NOMESCO Finland
Neuropsychological investigation
23.6
71.3
55
30
TAB00
NOMESCO Finland
Lumbar puncture
17.9
68.2
61
45
N05AH04
ATC
quetiapine; oral
10.2
67.1
102
164
N03AG01
ATC
valproic acid; systemic, rectal
16.7
63.8
59
46
Z2445
NOMESCO Finland
Psychologist
23.9
59.6
45
23
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
13.5
55.8
59
57
P20
ICPC
Memory disturbance
8.5
53.4
90
159
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
9.0
47.5
70
105
F06.7
ICD-10 Finland
Mild cognitive disorder
17.5
41.7
36
24
F02.09
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
39.7
37
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
9.9
39.6
51
64
P70
ICPC
Dementia
116.1
37.0
39
*
ZY010
NOMESCO Finland
Hospital outpatient
12.7
35.5
37
34
N06DX01
ATC
memantine; oral
77.3
35.2
39
6
N06DA02
ATC
donepezil; oral
53.1
34.0
40
9
N06DA03
ATC
rivastigmine; oral, transdermal
385.5
33.8
33
*
N05BA06
ATC
lorazepam; systemic, sublingual
8.9
32.1
44
59
A28
ICPC
Limited function/disability NOS
4.7
27.6
89
270
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
23.3
22
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
84.7
21.1
23
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
7.6
20.5
31
46
F0203, G310,
ICD-10 Finland
+∞
20.1
19
*
AA1AD
NOMESCO Finland
CT of head and brain
3.5
19.8
109
464
SPAT1245
SPAT
Provision of support and information to patient’s family members
8.7
19.5
26
33
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
+∞
19.0
18
*
F02.00
ICD-10 Finland
Dementia in Pick's disease without additional symptoms
+∞
19.0
18
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
5.7
18.5
38
77
N05BA04
ATC
oxazepam; oral
3.5
18.5
90
352
F0204, G310,
ICD-10 Finland
+∞
17.9
17
*
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
193.9
17.8
18
*
R41.3
ICD-10 Finland
Other amnesia
8.5
17.7
24
31
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.9
17.6
29
47
R41.0
ICD-10 Finland
Disorientation, unspecified
7.9
17.3
25
35
N06AX11
ATC
mirtazapine; oral
3.2
17.0
108
492
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
23.0
16.3
23
11
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.7
15.9
41
101
F0200, G310,
ICD-10 Finland
+∞
15.8
15
*
SPAT1234
SPAT
Support of social functional capacity
6.5
15.6
27
46
N06AB10
ATC
escitalopram; oral
3.6
14.8
58
194
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
7.2
14.8
23
35
SPAT1216
SPAT
Assessment of functional ability
3.4
14.1
64
235
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.7
13.8
27
52
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
+∞
13.7
13
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
10.7
13.6
26
27
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
148.1
13.6
14
*
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
148.1
13.6
14
*
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
27.6
13.6
18
7
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
5.5
13.2
27
54
ZY000
NOMESCO Finland
Hospital inpatient
30.3
13.2
17
6
IGY02
NOMESCO Finland
Psychiatric monitoring contact
18.6
12.7
19
11
N06AX26
ATC
vortioxetine; oral
6.1
12.7
23
41
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.7
12.6
31
73
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.6
12.5
25
49
F05.9
ICD-10 Finland
Delirium, unspecified
17.1
12.4
19
12
Z2446
NOMESCO Finland
Social worker
4.6
12.2
31
75
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
22.8
12.2
17
8
N05AX12
ATC
aripiprazole; systemic
13.5
11.9
20
16
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.0
11.8
37
105
N05AD01
ATC
haloperidol; systemic
10.1
11.8
23
25
IGY99
NOMESCO Finland
Other psychiatric treatment contact
68.4
11.7
13
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
68.4
11.7
13
*
G30.8
ICD-10 Finland
Other Alzheimer disease
+∞
11.5
11
*
RT250, ,
NOMESCO Finland
+∞
11.5
11
*
F02.04
ICD-10 Finland
Dementia in Pick's disease other additional symptoms of mixed type
+∞
11.5
11
*
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
125.9
11.5
12
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
11.1
67
287
A04
ICPC
Weakness/tiredness general
3.1
10.6
50
186
F0202, G310,
ICD-10 Finland
+∞
10.5
10
*
F01.9
ICD-10 Finland
Vascular dementia, unspecified
+∞
10.5
10
*
F0201, G310,
ICD-10 Finland
+∞
10.5
10
*
F22.0
ICD-10 Finland
Delusional disorder
24.7
10.4
14
6
F29
ICD-10 Finland
Unspecified nonorganic psychosis
10.8
10.2
19
19
N05CD07
ATC
temazepam; oral
3.1
10.1
50
191
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.4
9.8
20
40
N06AB04
ATC
citalopram; systemic
2.7
9.7
66
298
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
9.6
97
529
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
13.1
9.5
16
13
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
22.8
9.5
13
6
N03AX09
ATC
lamotrigine; oral
7.8
9.5
21
29
F06.4
ICD-10 Finland
Organic anxiety disorder
+∞
9.4
9
*
RT150, ,
NOMESCO Finland
+∞
9.4
9
*
SPAT1053
SPAT
Memory test
2.8
9.0
52
215
N06AX16
ATC
venlafaxine; oral
3.1
8.8
42
156
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
14.8
8.8
14
10
N99
ICPC
Neurological disease other
17.1
8.7
13
8
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
13.4
8.5
14
11
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
+∞
8.4
8
*
G30.0
ICD-10 Finland
Alzheimer disease with early onset
+∞
8.4
8
*
L28
ICPC
Limited function/disability (L)
2.6
8.3
59
271
-, ,
ICD-10 Finland
9.4
8.2
16
18
P99
ICPC
Psychological disorders other
10.6
8.2
15
15
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
8.2
8.0
17
22
N05BA01
ATC
diazepam; systemic, rectal
2.7
7.9
47
197
P28
ICPC
Limited function/disability (P)
46.5
7.8
9
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.2
7.6
21
54
U04
ICPC
Incontinence urine
3.8
7.5
24
69
R53
ICD-10 Finland
Malaise and fatigue
2.3
7.5
68
348
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
82.6
7.5
8
*
S06.0
ICD-10 Finland
Concussion
3.0
7.3
34
124
F02.0
ICD-10 Finland
Dementia in Pick disease
+∞
7.3
7
*
F064, G310,
ICD-10 Finland
+∞
7.3
7
*
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
7.3
7
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.4
7.3
28
91
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
31.0
7.2
9
*
N05AN01
ATC
lithium; oral
10.5
7.1
13
13
P29
ICPC
Psychological sympt/compl other
5.8
7.1
19
35
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.2
7.0
13
470
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.4
6.8
26
84
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
23.3
6.7
9
*
Z2221
NOMESCO Finland
Medical doctor
2.2
6.7
74
408
A06AD11
ATC
lactulose; oral
2.5
6.7
49
227
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.4
6.7
50
234
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
12.7
6.6
11
9
ZXY02
NOMESCO Finland
Neuropsychologist
71.7
6.5
7
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
6.4
100
626
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
11.5
6.4
11
10
F31.8
ICD-10 Finland
Other bipolar affective disorders
11.5
6.4
11
10
Z3226
NOMESCO Finland
Physiotherapist
2.3
6.3
55
275
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
6.3
81
473
F020, G310,
ICD-10 Finland
+∞
6.3
6
*
F02.01
ICD-10 Finland
Dementia in Pick's disease has other additional symptoms, mainly paranoidism
+∞
6.3
6
*
F060, G310,
ICD-10 Finland
+∞
6.3
6
*
IGV01
NOMESCO Finland
Psychiatric network contact
27.5
6.3
8
*
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
13.0
6.1
10
8
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
13.0
6.1
10
8
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
10.4
6.1
11
11
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
10.4
6.1
11
11
SPAT1101
SPAT
Orthostatic test
3.7
6.0
19
54
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
43
33
15.70
46.37
1.1
1.1
1.77
3.42
e6/l
1.43
30
26
42
33
15.25
44.64
1.1
1.2
146.10
104.96
e6/l
0.16
31
26
98
379
3.70
20.84
1.9
1.7
1351.13
1228.37
nmol/l
0.63
77
276
131
808
2.39
9.82
2.6
2.0
89.11
95.86
pmol/l
1.04
73
405
89
480
2.37
8.88
1.7
1.5
19.28
20.95
nmol/l
0.49
81
400
76
392
2.38
8.31
3.0
3.3
2.44
2.46
mmol/l
0.71
60
340
109
661
2.20
8.05
2.5
3.6
2.35
2.35
mmol/l
0.13
91
581
39
148
2.96
7.86
2.7
1.8
1.47
1.72
%
1.23
33
122
54
253
2.47
7.20
10.1
8.0
—
—
—
0
0
18
43
4.45
7.15
1.2
1.4
—
—
—
0
0
18
43
4.45
7.15
1.2
1.4
—
—
—
0
0
48
229
2.37
6.09
1.8
1.9
—
—
—
0
0
40
177
2.52
5.97
2.4
2.5
35.03
34.69
u/l
0.02
35
144
47
225
2.36
5.91
1.8
1.8
—
—
—
0
0
127
900
1.89
5.42
6.7
5.9
1.21
1.21
mmol/l
0.22
112
809
62
349
2.05
5.19
2.8
3.0
1.32
1.01
e6/l
0.56
34
207
119
851
1.80
4.72
3.9
4.8
35.70
35.17
g/l
0.45
105
795
132
975
1.80
4.68
6.7
6.7
1.21
1.21
mmol/l
0.20
107
817
56
319
1.99
4.49
1.8
1.8
—
—
—
0
0
104
732
1.75
4.22
3.7
3.4
—
—
—
0
0
89
599
1.78
4.22
2.6
2.0
368.35
224.03
u/l
0.56
79
556
14
46
3.17
3.59
1.1
1.2
—
—
—
0
0
8
14
5.87
3.37
1.0
1.1
—
—
—
0
0
83
581
1.66
3.27
3.8
3.3
0.24
0.55
e6/l
1.41
66
443
52
324
1.77
3.11
2.9
3.2
6.42
2.51
e6/l
0.63
24
184
10
266
0.35
2.91
3.2
5.0
39.40
31.78
%
—
5
170
41
249
1.78
2.66
9.0
7.0
1.15
0.92
mmol/l
0.08
33
201
18
81
2.32
2.61
2.0
3.3
4.04
4.41
pmol/l
0.41
11
73
8
20
4.10
2.59
1.0
1.1
—
—
—
0
0
63
435
1.61
2.55
1.6
1.8
429.31
438.76
pmol/l
0.10
51
353
46
677
0.60
2.46
3.0
3.9
5.54
9.67
mg/mmol
1.00
31
418
72
520
1.55
2.39
5.6
4.1
0.00
0.00
estimate
-0.00
12
173
158
1348
1.52
2.35
5.3
3.9
14.25
15.05
pmol/l
3.19
143
1184
163
1811
0.68
1.95
3.8
5.0
1.42
1.45
mmol/l
0.48
140
1625
0
54
0.00
1.88
0.0
1.5
—
—
—
0
0
32
204
1.66
1.77
3.4
2.3
7.45
8.65
ug/l
0.12
23
180
64
482
1.45
1.69
3.1
2.1
3.15
3.15
mg/l
0.00
57
418
159
1760
0.71
1.68
3.5
4.5
1.43
1.27
mmol/l
1.56
134
1571
6
19
3.21
1.67
1.0
1.1
—
—
—
0
0
91
733
1.39
1.65
2.4
2.2
74.08
80.35
nmol/l
1.45
78
639
0
44
0.00
1.53
0.0
1.3
—
—
—
0
0
38
529
0.66
1.51
1.6
1.6
1.62
1.34
mmol/l
1.31
33
430
167
1821
0.72
1.47
3.9
5.1
4.63
4.51
mmol/l
0.74
143
1650
20
118
1.76
1.46
1.8
1.6
—
—
—
0
0
172
1866
0.71
1.45
4.7
5.7
2.73
2.62
mmol/l
0.64
150
1679
162
1772
0.73
1.42
5.9
6.6
39.62
40.89
mmol/mol
0.90
149
1626
109
921
1.34
1.42
4.8
3.9
0.00
0.00
estimate
0.50
13
201
39
276
1.49
1.41
10.8
6.4
105.87
104.06
mmol/l
2.05
39
276
109
924
1.33
1.38
5.7
5.2
0.00
0.00
estimate
-0.00
13
187
110
935
1.33
1.36
4.7
3.9
0.00
0.00
estimate
-0.00
12
180
166
1501
1.35
1.32
6.6
7.9
81.22
80.86
u/l
0.03
147
1394
10
190
0.51
1.31
1.1
1.4
—
—
—
0
0
19
299
0.60
1.30
1.3
1.3
18.23
46.61
iu/ml
—
6
104
169
1829
0.74
1.30
4.8
5.2
6.20
6.10
mmol/l
0.32
152
1643
19
115
1.71
1.29
4.7
6.7
26.03
24.84
mmol/l
0.71
19
115
183
1686
1.37
1.24
6.3
4.7
2.56
2.02
mu/l
0.54
162
1486
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
71
1.88
1.22
2.2
2.5
0.38
0.36
u/ml
—
8
37
125
1095
1.30
1.20
5.1
3.4
58.71
54.81
u/l
0.11
112
991
18
275
0.63
1.10
1.4
1.3
1.79
12.93
u/ml
—
7
106
45
344
1.38
1.09
2.9
3.3
0.81
0.82
mmol/l
0.33
38
321
164
1767
0.77
1.07
19.0
15.6
76.79
74.26
ml/min/173m2
1.02
135
1447
72
855
0.77
1.03
2.4
2.6
—
—
—
0
0
194
1824
1.35
0.99
19.6
16.0
32.13
25.58
mg/l
1.27
148
1464
23
158
1.50
0.98
3.0
3.5
81.80
85.74
ng/l
0.12
15
140
13
77
1.73
0.97
2.3
2.0
41.96
37.18
g/l
—
7
68
84
718
1.26
0.93
5.2
4.1
—
—
—
0
0
18
119
1.55
0.91
1.8
1.3
—
—
—
0
0
94
816
1.25
0.91
4.1
4.1
62.75
42.38
ng/l
0.23
70
640
13
79
1.68
0.90
2.3
2.4
1.16
0.56
g/l
—
8
69
43
534
0.76
0.85
2.1
2.9
352.38
7055.55
umol/l
2.21
29
443
97
852
1.23
0.83
2.8
2.2
—
—
—
0
0
30
226
1.37
0.81
3.7
3.6
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
5.90
—
0
10
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
14
207
0.66
0.77
1.2
1.3
—
—
—
0
0
120
1095
1.19
0.66
8.1
9.2
4.65
4.13
e9/l
1.13
102
950
13
87
1.52
0.64
2.3
2.1
2.91
3.10
g/l
—
8
78
13
88
1.50
0.62
2.3
2.0
8.53
10.61
g/l
—
7
78
0
21
0.00
0.60
0.0
1.1
—
139.03
—
0
6
0
21
0.00
0.60
0.0
1.2
—
1.40
—
0
5
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
8
53
1.53
0.59
1.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
19
142
1.37
0.56
1.3
1.4
—
—
—
0
0
21
161
1.33
0.54
2.0
2.9
80.20
59.70
ml/min/173m2
—
5
71
9
63
1.45
0.53
1.0
1.3
—
—
—
0
0
125
1162
1.16
0.51
7.2
4.8
7.04
6.85
mmol/l
0.43
112
1090
46
393
1.21
0.51
4.2
3.7
53.90
173.23
ng/l
1.96
41
335
115
1068
1.15
0.47
4.5
6.5
10.53
11.80
umol/l
0.87
104
1010
13
95
1.39
0.44
2.3
2.0
4.81
3.64
g/l
—
8
86
13
95
1.39
0.44
2.3
2.0
—
—
—
0
0
13
95
1.39
0.44
2.3
2.0
7.26
7.56
g/l
—
8
86
5
31
1.63
0.43
1.4
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
13.80
—
0
15
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
0
18
0.00
0.40
0.0
1.6
—
13.72
—
0
18
0
18
0.00
0.40
0.0
1.7
—
317.18
—
0
18
66
726
0.87
0.38
2.6
3.1
782.29
1587.71
ng/l
2.72
59
621
200
1947
1.17
0.36
25.7
19.0
139.71
139.68
mmol/l
0.04
190
1893
77
832
0.89
0.33
4.8
5.4
2.82
2.72
ug/l
0.04
65
730
26
222
1.19
0.31
2.0
3.3
8.00
9.18
umol/l
0.17
21
198
200
1953
1.15
0.30
24.7
19.1
3.96
4.00
mmol/l
1.20
190
1900
190
1947
0.88
0.30
22.4
19.6
75.44
82.39
umol/l
3.75
190
1947
8
63
1.28
0.28
1.4
1.2
—
—
—
0
0
8
63
1.28
0.28
1.4
1.2
—
—
—
0
0
143
1376
1.10
0.27
3.1
4.3
12.84
14.11
mm/h
0.44
128
1245
5
74
0.67
0.26
1.0
1.0
—
—
—
0
0
5
38
1.32
0.23
1.4
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
53.73
—
0
11
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
128.82
—
0
11
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
186.56
—
0
14
6
50
1.21
0.20
1.7
1.6
—
—
—
0
0
6
50
1.21
0.20
1.7
1.6
—
—
—
0
0
7
60
1.17
0.18
1.7
1.5
—
—
—
0
0
48
448
1.09
0.17
2.2
2.3
—
—
—
0
0
44
472
0.92
0.17
2.4
3.1
0.96
0.82
ug/l
0.15
36
320
74
706
1.07
0.15
3.3
2.7
92.95
153.15
ug/l
3.39
64
642
37
345
1.09
0.14
1.5
2.4
11.40
12.88
umol/l
0.72
30
319
193
1954
0.93
0.12
11.3
11.4
23.33
25.42
u/l
1.27
180
1866
34
320
1.07
0.10
1.4
2.4
2.35
2.29
g/l
0.26
26
295
65
626
1.05
0.10
2.8
2.5
47.67
65.34
u/l
1.53
58
575
5
48
1.04
0.09
1.0
2.2
127.40
128.03
g/l
—
5
33
68
659
1.04
0.08
4.3
4.6
20.66
21.75
%
0.23
29
335
7
67
1.05
0.08
1.7
1.8
—
—
—
0
0
19
179
1.07
0.05
2.0
2.8
67.42
66.75
g/l
0.17
12
162
104
1030
1.02
0.02
11.6
15.6
1.07
1.32
inr
5.67
19
310
199
1998
0.98
0.01
29.7
23.7
39.77
40.00
%
0.24
185
1867
199
1998
0.98
0.01
29.5
23.5
4.35
4.46
e12/l
2.24
190
1922
199
1998
0.98
0.01
29.5
23.6
132.07
134.99
g/l
1.80
191
1958
199
1997
0.98
0.01
29.4
23.5
246.57
241.50
e9/l
0.46
190
1930
17
172
0.99
0.00
1.8
2.7
139.76
221.06
ng/l
0.79
17
153
11
109
1.01
0.00
4.4
2.6
1.27
1.07
%
0.48
11
109
156
1561
1.00
0.00
25.3
19.3
14.61
15.40
%
1.21
151
1537
37
365
1.02
0.00
1.3
1.2
0.69
1.38
u/ml
—
9
99
44
435
1.01
0.00
1.8
1.7
1.47
1.48
mg/l
0.01
33
345
11
106
1.04
0.00
4.2
2.6
0.62
0.68
%
0.31
11
106
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
2.0
—
97.00
—
0
9
0
7
0.00
0.00
0.0
1.0
—
10.64
—
0
7
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
6
62
0.97
0.00
1.7
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
762.89
—
0
9
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
1.30
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
-0.00
0.0
1.0
—
145.40
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
11.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
9.90
—
0
5
0
8
0.00
-0.00
0.0
5.8
—
217.00
—
0
8
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
80
1.00
-0.00
1.9
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: FTD_WIDE – Frontotemporal dementia, wide, incl. Pick's disease
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).